Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Orally active antidiabetic agents patented by Otsuka

March 26, 1999

Novo Nordisk's liquid somatropin approved in Denmark

March 26, 1999

Novo Nordisk studies compounds that interact with KATP channels

March 25, 1999

ACS presentation for LY-377604, Lilly's beta3-agonist for metabolic syndrome

March 24, 1999

Merck reveals progress in obesity/diabetes program at ACS meeting

March 24, 1999

ACS highlights: novel guanylureas as NPY Y1 antagonists presented by Alanex

March 24, 1999

Highly potent and selective sst2 receptor agonist: discovery and synthesis discussed at ACS meeting

March 24, 1999

Fluvastatin lowers LDL, raises HDL cholesterol

March 24, 1999

Romozin cannot be reintroduced in the U.K., MCA says

March 23, 1999

Lilly reports initial clinical data for LY-333531

March 23, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 1, 2026.
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
New evidence links autoimmunity to long COVID symptoms
BioWorld
Recent findings are reshaping current understanding of the post-infection landscape of SARS-CoV-2. Although previous studies had already suggested that...
Breakthrough as GSK’s bepirovirsen clears 19% of chronic hep B infections
BioWorld
GSK plc has announced a breakthrough in the treatment of chronic hepatitis B, reporting a functional cure rate of 19% across two phase III trials of its antisense...
BMS’ mezigdomide doubles PFS in multiple myeloma
BioWorld
Bristol Myers Squibb Co. disclosed in March 2026 that the phase III portion of the seamless phase II/III Successor-2 study testing mezigdomide in combination with...